ALX Oncology Holdings Inc. (ALXO)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Jaume Pons
Employees:
40
866 MALCOLM ROAD, SUITE 100, BURLINGAME, CA 94010
650-466-7125

ALX Oncology Holdings Inc. focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial. ALTA-002, a SIRPa TRAAC that offers ways to engage the innate and adaptive immune response to cancer.

Data derived from most recent annual or quarterly report
Market Cap 335.799 Million Shares Outstanding41.152 Million Avg 30-day Volume 362.925 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.87
Price to Revenue0.0 Debt to Equity0.0567 EBITDA-158.622 Million
Price to Book Value1.1704 Operating Margin0.0 Enterprise Value10.641 Million
Current Ratio5.665 EPS Growth0 Quick Ratio5.407
1 Yr BETA 1.0759 52-week High/Low 12.33 / 3.94 Profit Margin0.0
Operating Cash Flow Growth-29.4167 Free Cash Flow to Firm (FCFF) TTM -96.178 Million Free Cash Flow to Equity (FCFE) TTM-109.647 Million
Altman Z-Score-1.9157
View SEC Filings from ALXO instead.

View recent insider trading info

ALX Oncology Holdings Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ALXO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALXO

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-07-27 by RANDOLPH SOPHIA
  • 4: filed on 2023-07-27 by PINTO SHELLY
  • 4: filed on 2023-07-27 by PONS JAUME
  • 4: filed on 2023-07-07 by PINTO SHELLY
  • 4: filed on 2023-07-05 by RANDOLPH SOPHIA
  • 4: filed on 2023-07-05 by PONS JAUME
  • 4: filed on 2023-07-05 by PINTO SHELLY
  • 4: filed on 2023-06-22 by CANAMASAS ITZIAR
  • 4: filed on 2023-06-13 by RANDOLPH SOPHIA
  • 4: filed on 2022-12-20 by RANDOLPH SOPHIA

    • Events (8k)

  • 8-K: filed on 2023-11-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-04:
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2023-10-04:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-20:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-13:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-03-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    LETTMANN JASON CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 0 2023-09-08 2

    GARCIA PETER S CHIEF FINANCIAL OFFICER

    • Officer
    		 86,738 2023-07-25 3

    PONS JAUME PRESIDENT & CEO

    • Officer
    • Director
    		 625,538 2023-07-25 3

    RANDOLPH SOPHIA CHIEF MEDICAL OFFICER

    • Officer
    • Director
    		 315,477 2023-07-25 5

    PINTO SHELLY SVP, FINANCE AND CAO

    • Officer
    		 81,713 2023-07-25 4

    GOODMAN COREY S

    • Director
    • 10% Owner
    		 0 2023-06-20 1

    GARLAND J. SCOTT

    • Director
    		 0 2023-06-20 1

    NIELSEN JACK

    • Director
    • 10% Owner
    		 0 2023-06-20 1

    HEMRAJANI REKHA

    • Director
    		 0 2023-06-20 1

    CANAMASAS ITZIAR

    • Director
    		 0 2023-06-20 1

    LSV ASSOCIATES, LLC

    LIGHTSTONE VENTURES, L.P.

    LIGHTSTONE VENTURES (A), L.P.

    LSV ASSOCIATES II, LLC

    LIGHTSTONE VENTURES II, L.P.

    LIGHTSTONE VENTURES II (A), L.P.

    CARUSI MICHAEL A

    GEORGE JEAN

    PLAIN HENRY A JR

    • 10% Owner
    		 16,500,516 2021-12-13 0

    GRAHAM G. WALMSLEY

    • Director
    		 12,004 2021-06-11 0

    ADELMAN ROBERT J

    VENBIO GLOBAL STRATEGIC FUND, L.P.

    VENBIO GLOBAL STRATEGIC GP, LTD.

    VENBIO GLOBAL STRATEGIC FUND II L.P.

    VENBIO GLOBAL STRATEGIC GP, L.P.

    VENBIO GLOBAL STRATEGIC GP II, L.P.

    VENBIO GLOBAL STRATEGIC GP II, LTD.

    • 10% Owner
    • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
    		 9,895,737 2020-07-21 0

    PIETZKE STEFFEN VP FIN & CHIEF ACCT OFFICER

    • Officer
    		 3,000 2020-07-21 0

    VIVO CAPITAL IX, LLC

    VIVO CAPITAL FUND IX, L.P.

    VIVO OPPORTUNITY, LLC

    VIVO OPPORTUNITY FUND, L.P.

    • 10% Owner
    		 4,220,048 2020-07-21 0

    CAFFO NATHAN CHIEF BUSINESS OFFICER

    • Officer
    		 11,254 2020-07-21 0

    LSV ASSOCIATES, LLC

    LIGHTSTONE VENTURES, L.P.

    LIGHTSTONE VENTURES (A), L.P.

    LIGHTSTONE VENTURES II, L.P.

    LIGHTSTONE VENTURES II (A), L.P.

    LSV ASSOCIATES II, LLC

    CARUSI MICHAEL A

    GEORGE JEAN

    • 10% Owner
    		 0 2020-07-16 0

    VIVO CAPITAL IX, LLC

    VIVO CAPITAL FUND IX, L.P.

    • 10% Owner
    		 0 2020-07-16 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-06 20:45:03 UTC -1.022 6.342 250000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-06 20:15:04 UTC -1.022 6.342 250000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-06 19:45:04 UTC -1.022 6.342 200000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-06 19:15:04 UTC -1.022 6.342 200000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-06 18:45:03 UTC -1.022 6.342 200000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-06 18:15:03 UTC -1.022 6.342 200000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-06 17:45:03 UTC -1.022 6.342 200000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-06 17:15:04 UTC -1.022 6.342 200000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-06 16:45:04 UTC -1.022 6.342 200000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-06 16:15:04 UTC -1.022 6.342 200000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-06 15:45:03 UTC -1.022 6.342 200000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-06 15:15:04 UTC -1.022 6.342 150000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-06 14:45:04 UTC -1.022 6.342 150000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-06 14:15:04 UTC -1.022 6.342 150000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-06 13:45:04 UTC -1.0102 6.3302 150000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-06 13:15:04 UTC -1.0102 6.3302 150000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-05 22:15:04 UTC -1.0102 6.3302 150000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-05 21:45:04 UTC -1.0102 6.3302 150000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-05 21:15:04 UTC -1.0102 6.3302 150000
    ALX ONCOLOGY HOLDINGS INC ALXO 2023-12-05 20:45:04 UTC -1.0102 6.3302 150000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments